Holen Sie sich die Stockscreener-App
0.00
100.00%
-221.38
Cidara Therapeutics Inc Aktie (CDTX) Neueste Nachrichten
RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck - Gadsden Times
Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Is This Biotech Pioneer Poised for Growth? - DirectorsTalk Interviews
Cidara Therapeutics announces inclusion in the Russell 2000 and 3000 indexes - MSN
Block Trades: Is Cidara Therapeutics Inc benefiting from innovation trendsMarket Performance Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Cidara Therapeutics, Inc. (CDTX) Stock Report: Navigating a Biotech Trail with a Market Cap of $6.96 Billion - DirectorsTalk Interviews
CDTX SEC FilingsCidara Theraptcs 10-K, 10-Q, 8-K Forms - Stock Titan
Point72 entities disclose 1.4% Cidara Therapeutics (CDTX) stake in Schedule 13G/A - Stock Titan
Can Cidara Therapeutics Inc. sustain its profitabilityJuly 2025 Highlights & Low Risk High Reward Ideas - mfd.ru
Is Cidara Therapeutics Inc. being accumulated by smart money - mfd.ru
Is Cidara Therapeutics Inc. stock dividend yield sustainableJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - mfd.ru
How cyclical is Cidara Therapeutics Inc.’s revenue streamIPO Watch & Stepwise Trade Execution Plans - mfd.ru
Vivo Opportunity funds exit Cidara Therapeutics (CDTX) after merger completion - Stock Titan
Is Cidara Therapeutics Inc. benefiting from innovation trendsWeekly Trade Review & Weekly High Potential Stock Alerts - mfd.ru
RedChip Fintech & DATS Conference Replays Now Available Featuring Public Companies Shaping the Future of Digital Finance - USA Today
Merck Completes Tender Offer and Moves to Acquire Cidara Therapeutics - The Healthcare Technology Report.
Merck & Co., Inc. Q4 Earnings Call Highlights - MarketBeat
Portfolio Recap: How sensitive is Cidara Therapeutics Inc to inflationTrade Ideas & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Merck (MRK) Faces One-Time Charge Due to Cidara Acquisition - GuruFocus
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline - Business Wire
Aug Highlights: How sensitive is Cidara Therapeutics Inc to inflationQuarterly Investment Review & Free High Return Stock Watch Alerts - baoquankhu1.vn
Biotech Stocks Worth WatchingJanuary 8th - MarketBeat
Top Biotech Stocks To Watch NowJanuary 2nd - MarketBeat
Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Understanding the Dynamics of a $6.96 Billion Biotech - DirectorsTalk Interviews
Is Cidara Therapeutics Inc. on track to beat earnings2025 Pullback Review & Entry and Exit Point Strategies - Mfd.ru
Published on: 2026-01-28 17:40:21 - mfd.ru
Promising Biotech Stocks To ConsiderJanuary 4th - MarketBeat
Pharma News: What is the earnings history of Cidara Therapeutics IncWeekly Risk Report & Low Volatility Stock Recommendations - baoquankhu1.vn
Biotech Stocks To Add to Your WatchlistJanuary 7th - MarketBeat
Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating the Biotech Landscape with Potential Upside - DirectorsTalk Interviews
Biotech Stocks To Follow NowJanuary 5th - MarketBeat
Weekly Earnings: Is Cidara Therapeutics Inc benefiting from innovation trends2025 Key Lessons & High Conviction Trade Alerts - baoquankhu1.vn
Best Biotech Stocks To Keep An Eye OnJanuary 14th - MarketBeat
Support Test: Will Cidara Therapeutics Inc stock benefit from upcoming earnings reportsJuly 2025 Movers & Fast Entry Momentum Trade Alerts - Bộ Nội Vụ
Whale Trades: Will Cidara Therapeutics Inc. stock benefit from upcoming earnings reportsTrade Analysis Summary & Verified Swing Trading Watchlists - moha.gov.vn
This Biotech's Stock Price More Than Doubled on Friday. Here's Why. - MSN
Biotech Stocks To ConsiderJanuary 12th - MarketBeat
Biotech Stocks To Watch TodayJanuary 3rd - MarketBeat
Cidara Therapeutics prices upsized $350 milion stock offering at $44 - MSN
Cidara Therapeutics, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Merck to Buy Cidara in $9.2 Billion Deal as Sales Drop Looms - MSN
Top Biotech Stocks To ResearchJanuary 10th - MarketBeat
Why Cidara Therapeutics Inc. stock attracts high net worth investorsPortfolio Value Report & Long-Term Safe Investment Ideas - ulpravda.ru
What dividend safety score for Cidara Therapeutics Inc. stock2025 Trading Volume Trends & Breakout Confirmation Alerts - ulpravda.ru
Cidara Therapeutics (NASDAQ:CDTX) Upgraded at Wall Street Zen - MarketBeat
Promising Biotech Stocks To Keep An Eye OnJanuary 9th - MarketBeat
Cidara Therapeutics Completes Acquisition and Becomes Private Company - The Globe and Mail
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight - Benzinga
Cidara Therapeutics: Performance & Quotes, CDTX Stock Price on Nasdaq Exchange - marketscreener.com
Cidara Therapeutics, Inc.(NasdaqCM: CDTX) dropped from Russell 2000 Index - marketscreener.com
Will Cidara Therapeutics Inc. stock recover faster than marketEntry Point & AI Enhanced Trading Alerts - ulpravda.ru
Why Cidara Therapeutics Inc. stock appeals to analysts2025 Stock Rankings & Long Hold Capital Preservation Tips - ulpravda.ru
How sustainable is Cidara Therapeutics Inc. stock dividend payoutJuly 2025 Drop Watch & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Will Cidara Therapeutics Inc. (20D0) stock outperform global peersWeekly Market Report & Consistent Profit Focused Trading Strategies - ulpravda.ru
Merck completes purchase of Calif. company for $9.2 billion, adds flu-prevention drug to portfolio - roi-nj.com
ulpravda ru > 2026> Is Cidara Therapeutics Inc. stock recession proofOil Prices & Stock Portfolio Risk Control - ulpravda.ru
Working capital per share of Cidara Therapeutics, Inc. – FWB:20D0 - TradingView — Track All Markets
Cidara Therapeutics, Inc. (CDTX) Investor Outlook: Analyzing the Biotech’s Strategic Position Amidst a Record 52-Week High - DirectorsTalk Interviews
What market sentiment indicators show for Cidara Therapeutics Inc. (20D0) stockEarnings Date Calendar & Outstanding Investment Portfolio - ulpravda.ru
3.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):